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Background: Monitoring the impact of vaccine programs is necessary to identify changes in 
vaccine efficacy. We report the impact of the 12-year rotavirus vaccine program on diarrhea 
mortality and hospitalizations and their correlation to socioeconomic indicators. 
Methods: this ecological study describes diarrhea hospitalizations and deaths from 2006 to 
2018 in Brazil and correlates rotavirus-vaccine coverage, hospitalizations and deaths to 
socioeconomic indicators and social vulnerability index (SVI) by state and region. 
Hospitalizations, deaths and vaccine coverage trends were analyzed using Joinpoint 
regression models. Associations between hospitalizations, mortality and rotavirus 
vaccination coverage and socioeconomic and SVI indicators were established using Ordinary 
Least Square regressions. 
Results: Rotavirus vaccine coverage remained stable between 2006 and 2018 (annual 
percentage changes (APC) [95%CI]: 4.4% [-0.3%, 9.2%]). Diarrhea hospitalization rates 
decreased 52.5% (-5.7% [-7.5%, -3.8%]), from 68.4 to 32.5 hospitalizations per 10,000 
children <5 years-old between 2006 and 2018, with significant decreases in diarrhea 
mortality (-9.8% [-11.2%, -8.5%]). The Northeast region experienced the largest reductions (-
13.9% [-15.7%, -12.2%). Vaccination coverage and diarrhea-mortality were inversely 
correlated with the SVI. 
Conclusion: The burden of childhood diarrhea has decreased over an extended period. 
States with high SVI, but high vaccination coverage had the largest reductions in 
hospitalizations and deaths. 
Key-words: Acute diarrhea; Rotavirus; Rotavirus Vaccine; Mortality; Hospitalization; Brazil.  
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1. Introduction 
Diarrhea is a leading cause of childhood mortality, resulting in half a million annual deaths 
worldwide [1]. A major cause of severe diarrhea is Rotavirus, which is responsible for a high 
proportion of diarrhea hospitalizations in children. Two live Rotavirus vaccines were licensed 
in 2006 (Rotarix, GlaxoSmithKline Biologicals, Rixensart, Belgium and RotaTeq, Merck & Co. 
Inc., West Point, PA, USA) and were recommended by the World Health Organization (WHO) 
for worldwide implementation in 2009 [2]. Since then, the adoption of these and other 
Rotavirus vaccines by national immunization programs has reduced all-cause and rotavirus 
diarrhea-related hospitalizations and deaths in all countries where the vaccine has been 
implemented on a large scale [3–7]. However, vaccine efficacy varies between high and low 
income countries, with lower effectiveness reported from African countries [8]. Brazil 
introduced the Rotavirus (Rotarix®) vaccine in its national immunization program in March, 
2006, providing two doses free of charge to infants less than six months old, rapidly 
achieving high vaccination coverage, which resulted in significant decreases in diarrhea-
related hospitalizations and deaths [9]. Long term surveillance of vaccine effectiveness 
however is still necessary to demonstrate the continued benefits of the vaccine on public 
health important outcomes, enhancing vaccine confidence and support for its continued roll 
out, and to identify potential changes in the epidemiology of diarrhea [10]. Moreover, as the 
vaccine has been shown to have a lower efficacy in low-income countries [8], it is important 
to monitor whether vaccine efficacy varies within a large country, such as Brazil, with 
continental proportions and major sociodemographic differences [11,12]. 
We describe the impact of the rotavirus vaccination program on diarrhea-related mortality 
and hospitalization in Brazil, over an extended period of twelve years, and examine whether 
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these indicators are associated with the geographical regions’ socioeconomic indicators and 
social vulnerability index (SVI). 
2. Methods 
2.1. Study design and data sources 
This was an ecological study of all diarrhea hospitalizations and deaths of children less than 
5 years old reported in Brazil. Data on the number of diarrhea-related hospitalizations and 
deaths for children and the Rotavirus vaccine coverage (%) were obtained from the public-
domain Brazilian Hospital Information System of the National Health System (DATASUS) 
(http://datasus.saude.gov.br/). All hospitalizations and deaths of children with the 
International Classification of Diseases (ICD-10) codes A08–A09 were included. These codes 
correspond to all-cause diarrhea for both mortality and hospitalizations, as there are no 
large-scale diarrhea databases based on etiological diagnosis. Data was obtained by year for 
the five regions and each of the states of the country. In addition, data on the Human 
Development Index (HDI) and the SVI were obtained for each region and state of the 
country (http://www.br.undp.org/content/brazil/pt/home.html) The HDI describes the 
degree of human development and is categorized into longevity, education and income 
domains and ranges from 0 to 1; with higher values indicating higher human development 
[13]. The SVI , obtained from the Brazilian Institute of Applied Economic Research 
(http://www.ipea.gov.br), estimates the degree of vulnerability and social exclusion of a 
population. This index is composed of 16 social indicators of urban infrastructure, human 
capital, income and work [14] and ranges from 0 to 1, where 0 (zero) corresponds to no or 
very low social vulnerability and 1 to very high vulnerability. 
Other social indicators, including the Gini Index (Supplementary Material) were obtained 
from the Brazilian Institute of Geography and Statistics [15]. 
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2.2. Data analysis 
The trends of hospitalizations, deaths and vaccine coverage rates were analyzed using 
Joinpoint regression models (Joinpoint Regression Program 4.5.0.1, National Cancer 
Institute, USA) with Monte Carlo permutations. This method allows identifying trends and 
change points (i.e. the year that the trend changed) and determining annual percentage 
changes (APC). Trends were categorized as stable, increasing or decreasing, according to the 
slope of the regression line (whether positive or negative) and based on the 95% confidence 
interval (95% CI) and 5% significance.  
The association between the HDI and SVI and hospitalization, mortality and rotavirus 
vaccination coverage was established using Ordinary Least Square (OLS) regressions [16]. In 
the OLS model, the inclination of the regression line (positive or negative) indicates the 
direction of the association (direct or inverse). The residues of the model were submitted to 
Moran's statistics for the assessment of spatial dependence. If these were present, a spatial 
regression model was applied: or Spatial Error or the Spatial Lag Models. In the Spatial Error 
Model, spatial effects are noises that need to be removed, while the Spatial Lag Model 
attributes the ignored spatial autocorrelation to the response variable Y. Lagrange multiplier 
tests were used to the selection of the spatial model. The quality of the model was assessed 
by observing the Akaike, Schwarz Bayesian, R2, Log Likelihood and the I Moran statistic of 
the residues [17] using GeoDa 1.10 (Center for Spatial Data Science, Computation Institute, 
The University of Chicago, USA). 
2.3. Ethical considerations 
The study did not require approval from an ethics committee as databases are in the public 
domain without individual identifiers. 
3. Results 
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Trends on rotavirus vaccine coverage are shown in Fig 1A. The lowest vaccine coverage was 
46.5% in 2006, and the highest 95.4% in 2015. In Brazil, the vaccine coverage trend 
remained stable between 2006 and 2018 (APC: 4.4%; 95% CI: -0.3% to 9.2%; P= 0.1) (Table 
1). All regions showed an increasing trend in relation to vaccination coverage, despite a 
slight decline in rates from 2015 (Fig 1A and Table 1). The North, Northeast and Central-
West regions showed the largest increases in vaccination, with increases of 6.6%, 5.2% and 
5.4%, respectively. All states showed an increasing trend from 2006 to 2018, excepting the 
Federal District (APC: 1.8%; 95% CI: -1.2% to 4.9%; P= 0.2), which had a stable trend in 
vaccination coverage. 
A total of 46,292 diarrhea-related hospitalizations of children less than 5 years old were 
recorded from 2006 to 2018. The hospitalization rates ranged from 68.4 hospitalizations per 
10,000 children under 5 years-old in 2006 to 32.5 in 2018, resulting a 52.5% reduction in 
hospitalizations (APC: -5.7%; 95% CI: -7.5% to -3.8%; P< 0.001) (Fig 1B and Table 2). Diarrhea 
hospitalization rates decreased significantly in all Brazilian regions, with the largest 
reductions observed in the West Central (APC: -7.9%; 95% CI: -10.7% to -5.8%; P< 0.001) and 
Northeast (APC: -7.1%; 95% CI: -9.0% to -5.2%; P< 0.001) regions and the smallest 
reductions in the North region (APC: -2.9%; 95% CI: -4.8% to -1.0%; P: 0.006). Nearly all 
Brazilian states had decreasing hospitalization trends. Three states in the North region (Acre 
[APC: 6.7%; 95% CI: -6.1% to 21.3%; P: 0.3], Amazonas [APC: 0.1%; 95% CI: -2.4% to 2.7%; P: 
0.9] and Roraima [APC: 0.4%; 95% CI: -4.9% to 5.9%; P: 0.9]) and one state in the Northeast 
region (Maranhão [APC: -0.3%; 95% CI: -2.7% to 2.1%; P: 0.8) showed a stable trend. One 
state in the North region (Tocantins [APC: 4.7%; 95% CI: 0.7 to 8.8; P<0.001]) and one state 
in the Northeast region (Ceará [APC: -4.2%; 95% CI: 6.1 to -2.2; P<0.001]) had an increasing 
trend (Table 2 and Fig 2A). 
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There was a total of 11,137 diarrhea-related deaths in children under 5 years-old over the 
study period. The mortality rate ranged from 3.2 to 12.0 deaths per 10,000 children under 5 
years-old, with the highest and lowest rates observed in 2006 and 2018, respectively (Fig 
1C). Overall, there was a statistically significant decrease in mortality (APC: -9.8%; 95% CI: -
11.2% to -8.5%; P< 0.001), with the largest reductions occurring in the Northeast (APC: -
13.9%; 95% CI: -15.7% to -12.2%; P< 0.001) and the South Regions (APC: -8.2%; 95% CI: -
9.9% to -6.4%; P< 0.001) (Table 2). All states in the Northeast and South regions had 
decreasing mortality rate trends, while five of seven states in the North, three of four in the 
Southeast and three of four in the Central-West regions had stable trends (Table 2 and Fig 
2B). 
The distribution of the SVI by state is shown in Fig 3. The SVI was inversely associated with 
the state vaccination coverage (coefficient: -85.4; P< 0.001)., while there was no association 
between HDI and state vaccination coverage. There also were no associations between the 
SVI or the HDI and the hospitalization and mortality rates. Further sub-analysis of individual 
domains of the SVI identified that the urban infrastructure (coefficient: -26.4; P= 0.02) and 
human capital (coefficient -84.1; P= 0.009) domains were inversely associated with 
vaccination coverage; while the human capital (coefficient 119.0; P< 0.001) and income and 
work (coefficient: 87.2; P< 0.001) domains were directly associated with the mortality rates. 
There were no associations between the domains and hospitalization rates (Table 3). 
Similarly, a sub-analysis of the individual components of both the HDI and SVI identified 
seven indicators associated with vaccine coverage, including the percentage of children 
aged 0-5 and 6-14 years old not attending school, the proportion of the population with 
household income per capita ≤ half the 2010 minimum wage, the education index, the 
percentage of adults  with complete elementary school, low income among individuals at 
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work and the Gini index. Two components were also associated with mortality (the 
percentage of employers aged ≥18 years-old and the degree of formalization of employees 
≥18 years old) nut no components were associated with the hospitalization rates . Rotavirus 
vaccine coverage, diarrhea hospitalizations and mortality did not have a geographic 
association. The regression model indicated high vaccine coverage was directly associated 
with lower diarrhea mortality (coefficient -0.601948; P = 0.031) but not with diarrhea 
hospitalization rates (coefficient -0.00571481; P = 0.26). 
4. Discussion 
The introduction of rotavirus vaccination represented a step change in our ability to prevent 
acute diarrhea and to reduce infant morbidity and mortality. Rotavirus, historically a 
pathogen responsible for most severe cases of acute gastroenteritis in children under 5 
years-old, often represented 40%-50% of acute diarrhea hospitalizations and consultations 
to emergency services before the immunization era [18,19] and their impact on diarrhea 
hospitalizations and mortality was reported soon after their large scale introduction [5,7,20–
23]. Although the effectiveness of the rotavirus vaccine on the burden of diarrheal disease 
has already been reported [4,21,24], the assessment of the continued effectiveness of the 
rotavirus vaccination program after a prolonged period of implementation is necessary to 
confirm that vaccine efficacy has not changed over the years and that rotavirus incidence 
continues to be low, as other potential pathogens could have filled the ecological niche left 
empty by rotaviruses or the emergence of vaccine escapees.  
Our study includes information of an uninterrupted twelve-year mass vaccination program 
with a cohort of circa 3.0 million live births eligible for vaccination for each year. Our 
analysis identified stable trend in vaccination coverage and substantial reductions in 
diarrhea-related hospitalizations and deaths in Brazil. Despite the slight decline in 
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vaccination coverage in all regions from 2015 to 2018, vaccine coverage rates still remaining 
above 80%. Diarrhea-related hospitalizations and mortality have continued to decrease 
throughout  both periods, suggesting that diarrhea reduction follows a long term decreasing 
trend that started before the advent of the vaccines [21–23,25]. The 62% and 74% 
reductions in childhood diarrhea hospitalizations and deaths occurring in the study period 
have invariable been attributed to the Rotavirus vaccines. However, similar reductions had 
occurred in other Latin American countries, which are attributed to water and sanitation 
and nutritional improvements, with decreases in all-cause diarrhea hospitalizations and 
deaths before and after vaccine introduction [21]. Rotavirus is transmitted from person-to-
person mainly via fecal-oral route and, in settings with well-established urban and sanitation 
infrastructure, rotavirus is responsible for about 10% of episodes of acute diarrhea 
[9,26,27], suggesting that environmental control measures alone are insufficient to stop 
transmission [28–30]. Effective control therefore requires a multi-pronged approach and the 
reduction in the incidence of acute diarrhea after vaccine introduction is likely to have 
benefited from the synergistic effect of the long-term environment and sanitation 
improvements.  
The slight decrease in rotavirus vaccine coverage since 2015 coincided with the decline of 
other vaccines in the country [31]. This was due, in part, to the misinformation spread 
through social media [32], as caregivers of unvaccinated children believe misinformation of 
the role of the vaccines and fear adverse events, with 67% believing at least one factually 
inaccurate vaccine statement. The main source of misinformation are messaging apps and 
low income and low education population groups are more likely to believe false news [32]. 
Recent reviews of the causes and contributing factors for the low Rotavirus vaccine 
performance in low- and middle-income countries (LMIC) reported that enteric pathogens, 
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malnutrition, microbiota dysbiosis and environmental enteropathy [33,34], the passive 
transfer of Immunoglobin antibodies through maternal milk [34,35] and the concomitant 
use of Rotavirus and Polio oral vaccines could reduce vaccine efficacy [35]. These two last 
factors however may not play a significant role in Brazil, as only about one third of the 
mothers breastfeed exclusively their infants up to 6 months [36] of age and mothers may 
have a lower concentration of immunoglobulins because of the low Rotavirus prevalence in 
recent years. Moreover, in 2012 Brazil replaced the oral Polio vaccines for the inactivated 
Polio vaccine for the two first doses, at 2 and 4 months of age, which would have removed 
any possible interference. 
Our findings are unique in establishing an association between the SVI, rotavirus vaccination 
coverage and mortality, with the worst socioeconomic indicators associated with lower 
vaccination coverage and increased mortality. Although all regions of the country 
experienced reductions in hospitalizations and mortality rates, these reductions were less 
steep in the South and Southeast regions, which have the best social and economic 
indicators, than the Northeast region, with the worst social and economic conditions. This 
was unexpected as the rotavirus vaccine has been shown to be more effective in high 
income countries than in LMIC [6,21]. The Northeast region of Brazil had the highest decline 
in hospitalization rates and the second highest decline in deaths, suggesting regions with 
severe socioeconomic deprivation benefitted considerably more from the high vaccine 
coverage rates.  
Although we only have anecdotical evidence, factors that affect low vaccine efficacy, as 
malnutrition and breast milk [33,34] may play a less prominent role in Brazil. For example, 
undernutrition is less common and has been replaced by obesity, while breast feeding is less 
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common among younger generations, and the prevalence of other infections such as 
malaria have largely been eliminated except than the Amazonian region. 
In the North region, which has poor socio-economic indicators and living conditions, the 
reduction in hospitalization rates were lower than expected, as the region has similar social 
and economic indicators than the Northeast. Factors that could play a role are the higher 
number of villages without primary health care services, which may hinder disease 
prevention, awareness of hygiene practices and vaccine use and reduce the opportunities 
for vaccination [37,38]. Conversely, this region achieved significant reductions in mortality, 
possibly due to the vaccine preventing the most severe cases of acute diarrhea, if not 
hospitalizations. Similar findings have been reported from studies on vaccine effectiveness 
in other LMIC [8,39,40]. 
Despite the substantial gains in recent years, Brazil still has considerable diarrhea 
hospitalization and mortality rates in regions with high SVI. The high hospitalization rates 
may be explained by the diversity of pathogens co-circulating with rotavirus and, 
potentially, variations in rotavirus strains. Norovirus incidence has increased among children 
presenting to emergency pediatric services, especially in highly vaccinated rotavirus 
populations [41–43]. In addition, rotavirus genotypes have changed significantly in recent 
decades, with an unusual increase of strains heterotypic to the monovalent Rotavirus 
vaccine, which  elicits a slightly lower protection against fully heterotypic strains [25].  
Our study has several limitations. Data were obtained from routine information systems and 
represent information on patients who sought treatment and were reported, and thus 
children with mild diarrhea episodes and those not seeking health services are under-
represented, generating potential bias. Secondary data in ecological studies are also 
unsuitable to establish disease causality, and therefore, the study only provides evidence of 
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statistical associations and limits the possibility of exploring confounders. In addition, the 
data reported refer to cases of acute diarrhea without a defined etiology. 
5. Conclusion 
Brazil is an excellent example of a successful and large-scale rotavirus vaccination program, 
with its free provision of vaccines and high vaccination coverage rates in a large cohort of 
children. Despite the country’s major social and economic disparity and inequity, 
hospitalization and mortality rates in children have reduced in all regions. Conversely, our 
findings also highlight the influence of social vulnerability on rotavirus vaccine coverage and 
mortality, with the worst socioeconomic indicators occurring in areas with low vaccination 
coverage and with lower reductions in mortality. The lower vaccine coverage observed in 
the last 3 years has not resulted in increases on diarrhea mortality or hospitalizations but 
highlights the need for continued surveillance and the need to implement new strategies to 
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Table 1: Joinpoint regression analysis of rotavirus vaccine coverage in children under 5 years-old from 2006 to 2018. 
Region Period Rotarix vaccine coverage  
APC 95% CI P-value Trend 
North 2006-2018 6.6 13.2 to 2.1 <0.001 Increasing 
Rondônia 2006-2018 3.4 1.1 to 5.7 <0.001 Increasing 
Acre 2006-2018 11.9 8.9 to 15.1 <0.001 Increasing 
Amazonas 2006-2018 5.2 2.5 to 7.9 <0.001 Increasing 
Roraima 2006-2018 7.1 3.8 to 10.5 <0.001 Increasing 
Pará 2006-2018 7.8 2.9 to 12.9 <0.001 Increasing 
Amapá 2006-2018 6.5 1.7 to 11.5 <0.001 Increasing 
Tocantins 2006-2018 4.6 2.5 to 6.8 <0.001 Increasing 
Northeast 2006-2018 5.2 0.5 to 10.2 <0.001 Increasing 
Maranhão 2006-2018 7.0 2.3 to 12.0 <0.001 Increasing 
Piauí 2006-2018 5.3 2.8 to 7.9 <0.001 Increasing 
Ceará 2006-2018 7.0 4.5 to 9.5 <0.001 Increasing 
Rio Grande do Norte 2006-2018 6.4 1.9 to 11.1 <0.001 Increasing 
Paraíba 2006-2018 2.4 0.5 to 4.3 <0.001 Increasing 
Pernambuco 2006-2018 5.7 2.4 to 9.0 <0.001 Increasing 
Alagoas 2006-2018 8.4 5.0 to 11.8 <0.001 Increasing 
Sergipe 2006-2018 3.5 0.7 to 6.4 <0.001 Increasing 
Bahia 2006-2018 4.9 1.1 to 8.8 <0.001 Increasing 
Southeast 2006-2018 2.3 1.3 to 3.2 <0.001 Increasing 
Minas Gerais 2006-2018 3.5 1.4 to 5.7 <0.001 Increasing 
Espírito Santo 2006-2018 2.9 0.4 to 5.5 <0.001 Increasing 
Rio de Janeiro 2006-2018 4.7 0.9 to 8.6 <0.001 Increasing 
São Paulo 2006-2018 3.6 1.8 to 5.4 <0.001 Increasing 
Central-West 2006-2018 5.4 0.3 to 10.9 <0.001 Increasing 
Mato Grosso do Sul 2006-2018 3.3 0.6 to 5.9 <0.001 Increasing 
Mato Grosso 2006-2018 8.8 5.7 to 11.8 <0.001 Increasing 
Goiás 2006-2018 7.0 3.9 to 10.3 <0.001 Increasing 
Distrito Federal 2006-2018 1.8 -1.2 to 4.9 0.20 Stable 
South 2006-2018 4.2 0.1 to 8.5 <0,001 Increasing 
Paraná 2006-2018 4.5 2.0 to 7.1 <0.001 Increasing 
Santa Catarina 2006-2018 3.8 1.3 to 6.3 <0.001 Increasing 
Rio Grande do Sul 2006-2018 5.1 2.9 to 7.4 <0.001 Increasing 
Brazil 4.4 4.4 -0.3 to 9.2 0.1 Stable 
APC: annual percentage change 
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Table 2: Joinpoint regression analysis of hospitalization and mortality rates in children ≤ 5 years old due to infectious diarrhea in Brazil from 
2006 to 2018. 
Region Period Hospitalization rate  Mortality rate  
APC 95% CI P-value Trend APC 95% CI P-value Trend 
North 2006-2018 -2.9 -4.8 to -1.0 0.006 Decreasing -6.2 -8.0 to -4.4 <0.001 Decreasing 
Rondônia 2006-2018 -6.9 -9.3 to -4.5 <0.001 Decreasing -4.4 -10.8 to 2.4 0.2 Stable 
Acre 2006-2018 6.7 -6.1 to 21.3 0.3 Stable -3.0 -3.2 to 9.5 0.3 Stable 
Amazonas 2006-2018 0.1 .2.4 to 2.7 0.9 Stable -1.2 -4.4 to 2.2 0.5 Stable 
Roraima 2006-2018 0.4 -4.9 to 5.9 0.9 Stable -6.6 -20.2 to 9.5 0.4 Stable 
Pará 2006-2018 -3.0 -4.7 to -1.3 <0.001 Decreasing -11.1 -14.5 to -7.6 <0.001 Decreasing 
Amapá 2006-2018 -5.0 -9.3 to -0.5 <0.001 Decreasing -1.5 -11.4 to 9.5 0.8 Stable 
Tocantins 2006-2018 4.7 0.7 to 8.8 <0.001 Increasing -9.7 -16.8 to -2.0 <0.001 Decreasing 
Northeast 2006-2018 -7.1 -9.0 to -5.2 <0.001 Decreasing -13.9 -15.7 to -12.2 <0.001 Decreasing 
Maranhão 2006-2018 -0.3 -2.7 to 2.1 0.8 Stable -14.0 -17.0 to -10.8 <0.001 Decreasing 
Piauí 2006-2018 -6.0 -8.0 to -3.8 <0.001 Decreasing -13.8 -18.8 to -8.4 <0.001 Decreasing 
Ceará 2006-2018 -4.2 6.1 to -2.2 <0.001 Increasing -11.5 -16.1 to -6.7 <0.001 Decreasing 
Rio Grande do Norte 2006-2018 -7.9 -10.8 to -5.0 <0.001 Decreasing -7.9 -14.8 to -0.4 <0.001 Decreasing 
Paraíba 2006-2018 -9.5 -12.3 to -6.6 <0.001 Decreasing -24.1 -31.1 to -16.3 <0.001 Decreasing 
Pernambuco 2006-2018 -11.6 -13.9 to -9.3 <0.001 Decreasing -13.5 -16.8 to -8.4 <0.001 Decreasing 
Alagoas 2006-2018 -12.2 -14.1 to -10.4 <0.001 Decreasing -14.7 -19.3 to -9.9 <0.001 Decreasing 
Sergipe 2006-2018 -9.6 -16.5 to -2.1 <0.001 Decreasing -12.3 -16.9 to -7.5 <0.001 Decreasing 
Bahia 2006-2018 -10.0 -11.7 to 8.2 <0.001 Decreasing -13.2 -16.7 to -9.6 <0.001 Decreasing 
Central-West 2006-2018 -7.9 -10.7 to -5.8 <0.001 Decreasing -6.8 -9.7 to -3.8 <0.001 Decreasing 
Mato Grosso do Sul 2006-2018 -4.1 -6.6 to -1.6 <0.001 Decreasing -12.5 -17.9 to -6.7 <0.001 Decreasing 
Mato Grosso 2006-2018 -5.6 -8.5 to -2.5 <0.001 Decreasing -2.0 -6.5 to 2.6 0.3 Stable 
Goiás 2006-2018 -11.4 -14.4 to -8.3 <0.001 Decreasing -1.6 -7.2 to 11.3 0.7 Stable 
Distrito Federal 2006-2018 -7.2 -11.5 to -2.7 <0.001 Decreasing -10.8 -20.7 to 0.2 0.1 Stable 
Southeast 2006-2018 -5.2 -7.4 to -3.0 <0.001 Decreasing -5.8 -7.9 to -3.7 <0.001 Decreasing 
Minas Gerais 2006-2018 -6.7 -9.4 to -3.9 <0.001 Decreasing -8.3 -14.4 to -1.7 <0.001 Decreasing 
Espírito Santo 2006-2018 -3.1 -5.6 to -0.5 <0.001 Decreasing -7.3 -14.4 to 0.4 0.1 Stable 
Rio de Janeiro 2006-2018 -9.0 -11.7 to -6.1 <0.001 Decreasing -3.8 -9.8 to 2.6 0.2 Stable 
São Paulo 2006-2018 -4.3 -6.1 to -2.6 <0.001 Decreasing -7.2 -12.0 to -2.2 0.0 Stable 
South 2006-2018 -5.75 -7.7 to -6.3 <0.001 Decreasing -8.2 -9.9 to -6.4 <0.001 Decreasing 
Paraná 2006-2018 -4.1 -6.4 to -1.8 <0.001 Decreasing -12.2 -18.3 to -5.7 <0.001 Decreasing 
Santa Catarina 2006-2018 -4.1 -6.2 to -2.0 <0.001 Decreasing -8.4 -15.9 to -0.2 <0.001 Decreasing 
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Rio Grande do Sul 2006-2018 -11.4 -17.5 to -4.9 <0.001 Decreasing -7.1 -11.4 to -2.5 <0.001 Decreasing 
Brazil  2006-2018 -5.7 -7.5 to -3.8 <0.001 Decreasing -9.8 -11.2 to -8.5 <0.001 Decreasing 
APC: annual percentage change 
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 Table 3. Spatial Lag Model between Rotavirus vaccine coverage, hospitalization and mortality rates and socioeconomic indicators, Brazil, 
2006-2018. 
 Rotavirus vaccine coverage Hospitalization Mortality 
Social determinants Coefficient P-value Coefficient P-value Coefficient P-value 
Block 1- Synthetic indicators of social vulnerability and human development 
      
Constant 127.8 0.00133 2611.73 0.11596 -6.94113 0.83779 
Social Vulnerability Index (SVI) -85.4 0.00150 219.237 0.84140 27.7111 0.23402 
Human Development Index (HDI) -21.3 0.59612 -3069.29 0.10206 4.15583 0.91340 
Block 2- Social Vulnerability Index domains 
      
Constant 112.7 0.00000 -42.3172 0.86962 -9.79261 0.00748 
SVI Urban infrastructure -26.4 0.02007 53.5585 0.92156 -5.16754 0.47068 
SVI Human capital -84.1 0.00872 31.6206 0.98326 119.017 <0.0001 
SVI Income and work 33.4 0.23449 1510.22 0.28921 87.2292 <0.0001 
Block 3- Human Development Index (HDI) domains 
      
Constant 5.46 0.94135 799.415 0.76471 38.8407 0.51398 
HDI Longevity 57.3 0.71244 3174.47 0.57043 -30.7117 0.80413 
HDI Education 64.7 0.32833 -3981.12 0.10066 -11.9713 0.81883 
HDI Income -12.5 0.87685 -567.55 0.84515 -1.21521 0.98496 
Block 4- SVI Urban Infrastructure indicators 
      
Constant 85.3 0.00000 673.581 0.00050 10.1865 0.00329 
% of people in households with inadequate water supply and sewage 85.3 0.13407 4.68223 0.62016 -0.0297418 0.86566 
% of population living in urban households without garbage collection service 0.54 0.28477 -10.8064 0.55782 -0.307157 0.37420 
% of people living in households with a per capita income below half the minimum wage 
(in 2010) and spending more than an hour to work -0.14 0.28477 -15.4313 0.22589 -0.292306 0.21902 
Block 5- SVI Human Capital indicators 
      
Constant 93.1 0.00001 743.542 0.28728 -5.41726 0.66301 
Infant mortality -0.9 0.32422 -22.063 0.59359 -0.383776 0.60663 
% of children aged 0-5 years-old who not attending school -0.2 0.00566 -9.85047 0.49194 0.468188 0.08094 
% of people aged 6-14 years-old who not attending school -5.9 0.00239 82.5062 0.26334 1.86167 0.16571 
% of women aged 10-17 years-old who had children 8.9 0.05355 -206.815 0.27770 -5.24612 0.13277 
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% of mothers who are heads of household, who complete elementary school and with 
child under 15 years-old 0.6 0.39341 39.6639 0.20164 -0.0705729 0.89741 
Illiteracy rate of population aged ≥15 years-old. 0.4 0.70778 10.3425 0.79816 0.461057 0.52921 
% of children living in households where none of the residents have completed 
elementary school 0.03 0.94177 20.7857 0.34526 -0.0747096 0.84897 
% of people aged 15-24 years-old who do not study, do not work and have a per capita 
household income equal to or less than half the minimum wage (in 2010) -0.5 0.62626 -32.8931 0.43852 -0.0903655 0.90527 
Block 6- SVI Income and work indicators 
      
Constant 86.5 0.00004 570.175 0.43545 12.6567 0.30911 
Proportion of persons with per capita household income equal to or less than half the 
minimum wage (in 2010) 0.9 0.04565 11.2683 0.58579 0.331953 0.34657 
Population unemployment rate of persons aged ≥18 years-old -0.9 0.43090 -46.3278 0.46675 -1.28536 0.23802 
% of people aged ≥18 year-old without elementary school  -0.2 0.77779 7.46703 0.76941 0.00742866 0.98625 
% of people in households with per capita income below half the minimum wage (in 
2010) and dependent on the elderly 10.4 0.36700 -84.0648 0.67560 -3.5623 0.30027 
Occupancy rate of people aged 10-14 years-old 0.3 0.81915 -22.081 0.71499 -0.037787 0.97051 
Block 7- HDI Longevity  
      
Constant 43.4 0.52029 1680.54 0.49548 -48.9212 0.28382 
Life expectancy at birth 0.5 0.56202 -15.6899 0.63898 0.744588 0.23166 
Block 8- HDI Education 
      
Constant 10.7 0.89965 2277.05 0.54515 41.437 0.43625 
Education index 13528.7 0.03014 73417.2 0.77532 -4065.91 0.26951 
% of people aged ≥18 years-old who completed elementary school -135.5 0.03036 -757.163 0.76914 40.5458 0.27213 
School attendance index 1228.5 0.84147 -274395 0.31547 -1753.9 0.64546 
% of children aged 5-6 years-old in school -2.3 0.87932 682.017 0.31715 3.65387 0.70054 
% of children ages 11-13 years-old in the final years of elementary school or with 
complete fundamental -3.2 0.83194 671.266 0.31158 4.9008 0.59654 
% of people aged 15-17 years-old with complete elementary school -2.7 0.85969 703.6 0.30556 3.85336 0.68705 
% of people aged 18-20 years-old with complete high school -3.0 0.84949 688.111 0.32789 4.9418 0.61482 
Block 9 – HDI Income 
      
Constant 81.4 0.00000 629.85  0.00045 2.82477 0.33918 
Per capita income 0.0 0.78223 -0.147384 0.48379 0.00429165 0.27583 
Block 10 - Other indicators of social vulnerability and human development 
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Constant 1144.5 0.19771 8281.55 0.84635 468.917 0.35389 
Illiteracy rate in people aged ≥18 years-old. -25.3 0.18639 -154.647 0.86620 5.8621 0.58400 
Illiteracy rate in people aged ≥25 years-old 19.4 0.21869 194.201 0.79896 -4.37245 0.62214 
Per capita income of those vulnerable to poverty -0.5 0.44745 -12.1334 0.69852 -0.247088 0.49933 
% income due to personal work -0.5 0.03955 -3.16924 0.96141 0.0489985 0.94850 
Gini index -462.3 0.01804 4882.62 0.67614 -70.072 0.60560 
% of employees aged ≥18 years-old in formal work 2.8 0.74408 -235.351 0.58884 -9.37376 0.08377 
% of employees aged ≥18 years-old in unformal work -3.3 0.67812 -140.696 0.72681 -3.83863 0.41708 
% of workers aged ≥18 years-old in public sector 2.8 0.75321 -215.507 0.62853 -8.4125 0.12348 
% of self-employed workers aged ≥18 years-old -4.00 0.62396 -137.78 0.73628 -4.45832 0.35609 
% of employers aged ≥18 years-old 16.0 0.20658 -100.368 0.86945 -18.3372 0.02390 
Degree of formalization of the employed aged ≥18 years-old -7.5 0.05149 127.906 0.46685 5.19898 0.02412 
% of employed with complete elementary school aged ≥18 years-old -3.8 0.20253 131.483 0.37017 -0.145139 0.93050 
% of employed with complete high school aged ≥18 years-old 3.8 0.18161 -129.217 0.35040 0.425746 0.78618 
% of employed with undergraduate aged ≥18 years-old 0.3 0.92545 -80.0032 0.56394 -2.41423 0.15105 
Average income of employed persons aged ≥18 years-old 0.0 0.55681 0.626465 0.67693 0.0262186 0.15203 















Figure 3. Distribution of the Social Vulnerability Index (SVI) and their SVI domains by Brazilian state.
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eTable 1. Rotavirus vaccine coverage (%) by region/state and year. 
Region/State 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
North 32,04 62,27 64,28 72,27 68,18 72,26 74,46 83,14 84,11 83,09 77,83 73,43 78,64 
Rondônia 51,00 90,01 80,83 88,70 84,74 88,46 89,45 96,25 103,08 103,95 104,70 94,87 96,52 
Acre 17,60 51,47 55,22 68,67 66,75 72,29 73,76 73,49 66,43 82,50 76,81 75,98 82,15 
Amazonas 33,21 60,25 57,82 65,02 58,68 64,13 67,93 75,98 83,26 88,88 75,15 74,27 79,95 
Roraima 36,94 65,27 66,15 75,68 71,68 72,92 73,71 72,10 86,68 94,18 86,72 89,75 94,26 
Pará 26,51 56,39 62,21 69,93 66,89 71,51 74,00 85,97 82,24 72,51 69,33 64,75 70,66 
Amapá 34,28 63,16 68,14 78,41 73,53 68,11 72,56 75,48 77,35 82,33 95,33 71,75 76,46 
Tocantins 48,48 83,36 81,45 88,02 83,61 86,33 83,12 90,19 91,90 97,73 91,00 89,01 92,38 
Northeast 40,50 75,46 78,75 84,51 78,30 82,74 83,00 90,25 90,71 94,25 85,78 81,18 90,79 
Maranhão 32,94 62,95 69,23 78,26 72,83 77,84 79,20 88,99 87,76 90,71 74,24 70,61 81,58 
Piauí 37,71 79,41 84,11 89,68 80,01 84,91 86,36 89,57 82,24 85,48 78,54 76,85 84,54 
Ceará 41,73 85,67 88,77 90,97 87,61 88,44 88,66 95,74 97,49 107,60 112,01 102,11 113,27 
Rio Grande do Norte 35,21 67,49 71,81 76,46 75,77 82,55 83,41 86,11 88,24 89,86 76,75 68,99 85,12 
Paraíba 54,39 83,07 82,82 87,41 77,09 84,38 79,63 89,81 92,47 92,51 88,90 84,61 95,28 
Pernambuco 43,30 81,34 85,30 90,73 83,27 89,76 90,53 94,63 97,19 100,78 93,79 83,08 94,53 
Alagoas 31,33 61,69 68,16 79,38 74,79 69,84 75,58 84,87 85,96 90,10 83,30 84,41 97,01 
Sergipe 51,96 92,62 88,18 92,20 89,50 95,08 89,67 98,91 94,90 92,63 84,28 81,75 92,40 
Bahia 40,81 72,20 74,28 79,97 72,14 77,90 77,69 85,93 86,41 88,36 74,05 74,70 78,92 
Southeast 55,11 86,10 86,06 89,29 88,22 92,96 90,47 96,59 95,05 98,52 91,48 88,13 92,08 
Minas Gerais 57,15 91,75 91,39 95,33 93,22 96,22 93,79 99,12 98,57 101,89 92,20 88,58 96,87 
Espírito Santo 59,60 91,14 90,85 94,48 91,04 97,07 94,35 97,26 98,42 98,00 91,78 83,18 93,17 
Rio de Janeiro 48,58 76,93 76,19 80,26 78,90 85,42 82,66 90,89 93,47 98,91 93,67 83,36 88,97 
São Paulo 56,19 86,54 86,87 89,57 89,24 93,95 91,56 97,51 93,85 97,00 90,32 90,16 91,10 
South 49,71 83,39 84,56 88,55 88,58 90,67 89,94 95,75 97,18 98,23 91,74 88,29 89,55 
Paraná 50,13 83,51 85,74 89,67 91,66 93,21 91,65 98,68 98,68 99,75 90,74 89,07 88,41 
Santa Catarina 57,21 91,57 88,65 94,04 93,35 96,72 96,43 96,26 99,89 107,21 98,79 92,50 92,45 
Rio Grande do Sul 44,76 78,24 80,68 83,88 82,18 84,06 83,97 92,17 93,79 90,85 88,29 84,69 88,84 
Central-West 41,75 83,83 84,89 90,08 87,01 88,85 89,60 100,99 101,58 95,27 97,93 88,53 89,98 
Mato Grosso do Sul 55,34 86,58 84,78 91,64 87,57 93,07 91,36 104,10 127,91 117,69 97,89 92,83 96,07 
Mato Grosso 28,84 74,54 81,76 89,58 85,63 88,31 90,05 94,02 97,76 99,35 90,78 83,46 91,71 
Goiás 33,82 85,25 85,50 88,49 86,51 92,49 90,40 102,48 96,28 96,99 87,81 88,41 87,69 
Distrito Federal 59,79 88,69 87,30 92,34 89,00 78,35 85,89 103,12 91,84 65,45 129,62 90,99 86,97 





eTable2. List of additional social indicators used in the study. 
 
Illiteracy rate in people aged ≥18 years-old 
Illiteracy rate in people aged ≥25 years-old 
Per capita income of those vulnerable to poverty 
% income due to personal work 
Gini index 
% of employees aged ≥18 years-old in formal work 
% of employees aged ≥18 years-old in unformal work 
% of workers aged ≥18 years-old in public sector 
% of self-employed workers aged ≥18 years-old 
% of employers aged ≥18 years-old 
Degree of formalization of the employed aged ≥18 years-old 
% of employed with complete elementary school aged ≥18 years-old 
% of employed with complete high school aged ≥18 years-old 
% of employed with undergraduate aged ≥18 years-old 
Average income of employed persons aged ≥18 years-old 
% of employed persons without income aged ≥18 years-old 
Note: The values for these indicators were taken from the 2010 Census of the Brazilian Institute of Geography and Statistics. 
 
